Article Text

Download PDFPDF
Response to: ’Umbilical-cord messenchymal stem cells for the treatment of automimmune diseases: beware of cell to cell contact' by Alunno et al
  1. Teck Onn Lim1,
  2. DanQi Deng2,
  3. Peilian Zhang2,
  4. Yun Guo2
  1. 1 ClinReserach SB, Petaling Jaya, Selangor, Malaysia
  2. 2 Second Affiliated Hospital of Kunming Medical University, SLE Research Centre, Kunming, Yunnan, China
  1. Correspondence to Dr. Teck Onn Lim, ClinReserach SB, D7-3-1, Pusat Perdagangan Dana 1, Jalan PJU 1A/46, Petaling Jaya, Selangor, Malaysia; limteckonn{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We thank the authors of the eLetter1 for comments on the possible pitfall in the design of trial of umbilical cord derived mesenchymal stem cell (UC-MSC) for the treatment for lupus nephritis or other autoimmune diseases. It is worth bearing in mind that our trial …

View Full Text


  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles